*FDA PANEL SAYS BIOGEN ALS DRUG DATA LIKELY TO PREDICT BENEFIT *FDA PANEL SAYS BIOGEN ALS DRUG DATA LIKELY TO PREDICT BENEFIT *9-0 VOTE IN FAVOR OF ALS DRUG MAY PAVE WAY FOR FDA APPROVAL *BIOGEN DRUG COULD BECOME FIRST FOR RARE GENETIC FORM OF ALS